CVS Drops Obesity Drug; Once-Weekly Growth Hormone; WeightWatchers’ Bankruptcy
(MedPage Today) -- Many patients may have to switch obesity drugs now that CVS Caremark opted to stop offering tirzepatide ...
The FBI is getting new technology to see through walls
FBI headquarters in Washington DCShutterstock/Bob Korn The US Federal Bureau of Investigation (FBI) plans to buy radar technology that can ...
FDA, RFK Jr. Aim to Remove Ingestible Fluoride Products Used to Protect Kids’ Teeth
(MedPage Today) -- U.S. health regulators announced plans Tuesday to phase out ingestible fluoride-containing supplements sometimes used to strengthen children's ...
Would You Recognize the Signs of Trafficking in a Patient?
(MedPage Today) -- A recent episode of HBO Max's "The Pitt" brought human trafficking into primetime television, showcasing a young ...
Late Abortions Are Rare. The U.S. Just Lost a Clinic That Performed Them Since 1973.
(MedPage Today) -- To fellow travelers, Hannah Brehm likely looked like she was taking a belated babymoon well into her ...
Polarized and Politicized: Can We Find Middle Ground in Youth Gender Care?
(MedPage Today) -- A recent HHS report questioning the origins of gender dysphoria, rejecting medical interventions for transgender adolescents, and ...
Aeronutrients: The wild idea that we all get nutrition from the air that we breathe
Could aeronutrients explain the benefits of being in nature?Daniel Ernst/Stills Around 10 years ago, British tabloid newspaper The Sun ran a ...
‘Frustration is a huge part of my life with ADHD’
Henry is a tour guide who works in central London. He also has ADHD – attention deficit hyperactivity disorder - ...
Global Progress Continues on Reducing Rotavirus Burden, With Caveats
(MedPage Today) -- The introduction of the rotavirus vaccine has had a profound impact on global pediatric deaths from acute ...
Breast cancer gene families given hope by drug trial
A new treatment approach can significantly improve survival rates for patients with aggressive, inherited breast cancer, a study suggests.The trial, ...
USPSTF Reaffirms Universal Syphilis Screening in Pregnancy
(MedPage Today) -- The U.S. Preventive Services Task Force (USPSTF) renewed its recommendation for early and universal screening for syphilis ...
Pfizer Confirms: Leading JAK Inhibitor Often Comes With Weight Gain
(MedPage Today) -- Patients taking tofacitinib (Xeljanz) in the drug's late-stage and post-marketing studies were more likely than those on ...
Massive wildfires in Canada helped keep the world cooler in 2023
A wildfire rages in British Columbia, Canada, in June 2023Imago/Alamy Stock Photo 2023 smashed the record for the hottest year, ...
Biden’s Prostate Nodule; RFK Jr. Swims in Sewage-Tainted Creek; Stockpiling Drugs
(MedPage Today) -- Note that some links may require registration or subscription. Former President Joe Biden required "further evaluation" after ...
Ozempic-Like GLP-1 Drugs May Lower Cancer Risk Up to 41%
Share on PinterestA new study shows GLP-1 drugs liraglutide, exenatide, and dulaglutide were 41% more effective at preventing obesity-related cancers. ...
Inquiry hears Essex mental health trusts ‘try to stop’ coroner reports
Stuart WoodwardBBC News, EssexReporting fromLampard InquiryJamie Niblock/BBCDeborah Coles said the behaviour of some NHS trusts at inquests was "reprehensible"Health trusts ...
Parkinson’s disease could be detected by listening to someone’s voice
Difficulty speaking is a common Parkinson’s symptomSvetaZi/Shutterstock Parkinson’s disease lacks a conclusive test, so it is generally diagnosed by assessing ...
Some children at obesity clinics have BMI of 50
Getty ImagesA disproportionate number of children referred to NHS excess weight clinics in England are from the most deprived areas, ...
House Committee Proposes Budget Bill With $715B in Medicaid, Other Healthcare Cuts
(MedPage Today) -- WASHINGTON -- House Republicans unveiled a budget proposal that includes an estimated $715 billion in cuts to ...
Alzheimer’s Brain Edema, Bleeding Rates Reported in Lecanemab Real-World Study
(MedPage Today) -- Treating early Alzheimer's disease patients with lecanemab (Leqembi) was feasible and most patients tolerated the drug well, ...
